¹Kataria K, Dhar A, Srivastava A, Kumar S, Goyal A. A systematic review of current understanding and management of mastalgia. Indian Journal of Surgery, 2014. https://doi.org/10.1007/s12262-013-0813-8
Key takeaways
- Breast tenderness during menopause is common and is usually driven by fluctuating oestrogen and progesterone levels, particularly during perimenopause when cycles become irregular and ovulation becomes unreliable.
- Breast pain alone is rarely a sign of breast cancer, but certain accompanying symptoms do warrant prompt medical attention. This article sets out clearly what to look for.
- There are practical, evidence based ways to relieve breast tenderness, and if HRT is part of your treatment plan, specialist monitoring means that any tenderness can usually be resolved with a dose or formulation adjustment.
Sore, heavy, or tender breasts are not a symptom most women expect when they think about menopause. Hot flushes, yes. Sleep disruption, yes. But breast tenderness, especially when it arrives or intensifies in the years before periods stop, often catches women off guard.
It is, however, very common. Breast pain (known clinically as mastalgia) accounts for up to 50% of breast outpatient referrals, according to a systematic review published in the Indian Journal of Surgery (Kataria et al., 2014). Two of the most consistent concerns women bring to those appointments are fear that the pain signals something serious, and the impact the pain is having on daily life. Both are understandable. Both deserve a direct, honest answer.
This article covers why breast tenderness happens during menopause and perimenopause, the clinical distinction between cyclical and non-cyclical breast pain, practical evidence based relief, and the clear signs that do warrant medical assessment.
Is breast tenderness during menopause normal?
Yes, and it is more common in perimenopause than at any other stage of the menopausal transition.
The large majority of cases of breast pain are not associated with malignancy. A retrospective cohort published in the Turkish Journal of Surgery (Dogan et al., 2025) involving 840 patients presenting with mastalgia found that 41.6% had pain alone with no lump, and that mastalgia is predominantly not associated with malignancy. Any new lump or localised change does warrant thorough evaluation, and the red flags are covered clearly later in this article.
This matters because the anxiety that accompanies breast tenderness in this age group is real and understandable. If you are in your mid-40s or early 50s, noticing new breast soreness, and aware that breast cancer risk increases with age, it is entirely reasonable to feel unsettled. The evidence is reassuring, but reassurance is not the same as dismissal.
"Breast tenderness that fluctuates, affects both breasts, and accompanies other menopause symptoms is almost always hormonal in origin. You are not alone in experiencing it, and it is not something you simply have to endure.”
Why does menopause cause breast tenderness?
The short answer is fluctuating hormones. The more useful answer involves understanding what is specific about perimenopause.
Throughout reproductive life, oestrogen and progesterone rise and fall in a coordinated pattern across the menstrual cycle. Breast tissue is responsive to both hormones. Oestrogen promotes fluid retention and cell growth in breast tissue, while progesterone tempers those effects in the second half of the cycle. When the two hormones are in balance, tenderness may be mild and predictable.
Perimenopause disrupts this balance in a specific way. As ovarian function becomes erratic, cycles increasingly occur without ovulation. These are known as anovulatory cycles. In an anovulatory cycle, oestrogen rises as usual but progesterone does not follow, because progesterone is produced by the corpus luteum (the structure that forms after ovulation) and without ovulation there is no corpus luteum. The result is a period of unopposed oestrogen exposure that stimulates breast tissue without the balancing effect of progesterone.
Research published in Climacteric (Hale et al., 2003) established that breast tenderness and night sweats peak in the same premenstrual window in mid-life women, providing clinical diary evidence for this shared hormonal driver. More recently, a prospective observational cohort published in PLOS ONE (Wood et al., 2025) found that breast tenderness was reported by 68% of a random sample of approximately 900 premenopausal women, with the association between ovulatory disturbance and breast tenderness directly relevant to the perimenopausal mechanism.
After the final period, oestrogen levels stabilise at a lower level and the erratic fluctuations ease. For many women, cyclical breast tenderness improves once they are through the transition. Non-cyclical tenderness may persist or arise independently, which is why the distinction between the two patterns matters.
Cyclical vs non-cyclical breast pain: what is the difference?
Not all breast tenderness during the menopause transition is the same, and understanding the distinction helps clarify what is happening and what is likely to help.
Cyclical breast pain follows the hormonal pattern of the menstrual cycle. It is typically worse in the week or two before a period and eases when bleeding begins. It tends to affect both breasts, is often described as heaviness, aching, or sensitivity to touch, and is most common during perimenopause when cycles are irregular and hormone fluctuations are at their most unpredictable. NICE's Clinical Knowledge Summary on cyclical breast pain identifies this as the most common form of mastalgia in women of reproductive age, including women in perimenopause.
Non-cyclical breast pain has no relationship to the menstrual cycle. It may be persistent or intermittent, tends to be more localised, and is more common after menopause when regular cycles have stopped. Non-cyclical pain has a broader set of possible causes, some of which are structural rather than hormonal.
Understanding which pattern fits your experience helps. Cyclical pain typically responds to hormonal stabilisation, whether through natural progression to post-menopause or through treatment. Non-cyclical pain may need different investigation, as reviewed in Cornell et al., Mayo Clinic Proceedings (2020).
Other causes of breast tenderness: it is not always hormonal
While hormone fluctuation is the most common driver of breast tenderness during the menopause transition, it is not the only one. Understanding the full picture prevents unnecessary worry and means that pain with a non-hormonal cause is not left unaddressed.
Breast tissue changes. From the mid-30s onwards, glandular breast tissue is gradually replaced by fat, a normal structural change that can cause tenderness, particularly non-cyclical pain, as the tissue composition shifts. This process continues after menopause and is not a cause for concern, though it can contribute to ongoing discomfort.
Costochondritis and chest wall pain. Pain that appears to come from the breast sometimes originates from the chest wall, specifically inflammation of the cartilage connecting the ribs to the breastbone, known as costochondritis. This is easy to mistake for breast pain and can be identified by its reproducibility: pressing on the affected area of the chest wall typically recreates it. Muscle strain from posture or exercise can produce a similar pattern.
Ill-fitting bra. Inadequate breast support places strain on breast ligaments and can cause or worsen tenderness. This is a very common and often overlooked contributor, and it is one of the simplest to address.
Medication side effects. Some medications can “occasionally” cause or worsen breast tenderness. SSRIs (antidepressants sometimes prescribed for menopausal mood symptoms), aromatase inhibitors, and some blood pressure medications have all been associated with breast tenderness. If you started a new medication around the time your tenderness appeared, it is worth raising with your prescriber.
Caffeine and fluid retention. There is observational evidence that high caffeine intake and high salt intake can worsen breast tenderness through fluid retention. The evidence is not conclusive, but reduction is low risk and worth trying.
How to relieve breast tenderness during menopause
The evidence hierarchy for managing breast tenderness, as set out in both NICE CKS on cyclical breast pain and the Mayo Clinic Proceedings systematic review (Cornell et al., 2020), starts with reassurance and lifestyle measures, not medication. Most women find their symptoms improve with straightforward adjustments.
A well-fitted, supportive bra. Particularly at night: a soft, non-wired bra worn during sleep can significantly reduce discomfort. Or during exercise: a well fitted, correct level of impact sports brad. The Cornell et al. review cites this as one of the first line approaches, including for women with moderate tenderness.
Reduce caffeine and salt. Cutting back on caffeine and avoiding high-salt foods may reduce fluid retention in breast tissue. The evidence is observational, but the change is harmless and often helpful.
Topical NSAIDs (anti-inflammatory gels). For women who need more than lifestyle adjustment, topical NSAIDs such as ibuprofen or diclofenac gel applied directly to the breast are supported by the strongest evidence of any non-hormonal treatment. The Cornell et al. systematic review found topical NSAIDs provide relief in 70 to 92% of cases. They are preferred over oral NSAIDs for this indication because local application limits systemic absorption.
Heat or cold. Warm compresses or a cool pack can provide short-term relief during periods of acute tenderness. Neither changes the underlying hormonal driver, but both can make a meaningful difference day to day.
Evening primrose oil and vitamin E. These are sometimes mentioned for mastalgia. The evidence is mixed and neither sits within NICE's recommended treatment pathway. Some women find them helpful; there is no strong clinical basis for recommending them as a primary approach. Evening Primrose oil should be discussed with GP before use, to rule out interactions with any other medications if relevant.
HRT and breast tenderness: can it help or make it worse?
This is where the picture becomes more nuanced, and where getting the right advice matters. HRT can both cause and relieve breast tenderness, depending on your individual hormonal history and the type of HRT you are using.
For women who had hormone-driven breast tenderness in perimenopause, HRT may actually reduce it over time by stabilising the erratic oestrogen fluctuations that were causing the problem. Replacing unpredictable peaks and troughs with a consistent hormonal level removes the trigger.
For women starting HRT for the first time, particularly higher-dose oestrogen preparations, breast tenderness is a recognised initial side effect. It typically settles within two to three months as the body adjusts. A narrative review published in Breast Care (Sourouni and Kiesel, 2023) reviews the evidence on HRT and breast tissue, noting the importance of balanced, individualised prescribing.
If breast tenderness persists beyond the initial adjustment period while on HRT, this is not something to accept without review. Formulation, dose, and the type of progestogen used all affect breast tissue response. A specialist can adjust your prescription to address the problem. This is one of the concrete reasons ongoing specialist oversight matters. A brief GP appointment is unlikely to provide the time needed to review your full hormonal picture and make a considered adjustment.
Voy outcome data, presented at The Menopause Society 2025 (forthcoming in Climacteric), found that 88% of members felt more hormonally balanced at three months, compared to 62% of women receiving standard care. That gap reflects what specialist led, monitored care delivers when there is time and expertise to adjust treatment rather than simply initiate it.
On HRT and breast cancer risk: this concern is real and common, and it deserves an honest answer. For most women, the absolute increase in risk associated with HRT is small and varies depending on the type of HRT, duration of use, and individual health history. A narrative review published in Breast Care (Sourouni and Kiesel, 2023) concludes that HRT can lead to little or no increase in breast cancer risk in many contexts. Individual risk assessment is exactly what a specialist consultation is for. Your own history, family history, and health profile all matter, and a 45-minute consultation with a BMS-trained menopause specialist is the appropriate setting for that conversation.
When should you seek help for breast tenderness during menopause?
Most breast tenderness during menopause is hormonal, self-limiting, and manageable. There are, however, specific signs that do warrant prompt medical assessment.
See your GP if you notice:
- A new lump or thickening in the breast or armpit
- Changes to the skin over the breast: dimpling, puckering, redness, or an orange-peel texture
- Nipple discharge, particularly if it is bloodstained, from one breast only, or appears without squeezing
- Pain confined to one area of one breast that is persistent, worsening, or not explained by any of the causes above
- Any breast change that is new and does not resolve within a few weeks
Diffuse breast tenderness that fluctuates with your hormonal state and affects both breasts is not on this list. As confirmed by the Dogan et al. cohort (Turkish Journal of Surgery, 2025), mastalgia is predominantly not associated with malignancy. But this is not an instruction to dismiss pain that concerns you. If something has changed and you are not sure whether it warrants attention, a proper assessment will answer that question, and peace of mind has its own value.
If breast tenderness is part of a wider set of symptoms affecting your sleep, your mood, or your daily life, that is the kind of full picture a menopause specialist needs to see. Voy's 45-minute consultations with BMS-trained specialists provide the time to assess symptoms properly, understand how they relate to each other, and adjust treatment so that symptoms like breast tenderness do not become something you simply manage around. In Voy's outcome data, 93% of members reported an improvement in overall quality of life after starting treatment, from data presented at The Menopause Society 2025 (forthcoming in Climacteric). That figure reflects what happens when menopause care goes beyond a single prescription to address the whole picture.
